Works matching IS 22974725 AND DT 2016 AND VI 32 AND IP 4
Results: 29
Valganciclovir HEXAL® 450 mg Filmtabletten - neue 30er-Packung ergänzt das Portfolio.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 303
- Publication type:
- Article
Indikationsspektrum von Ipsens Lanreotid Autogel® in aktualisierten ENETS-Leitlinien deutlich erweitert.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 303
- Publication type:
- Article
Palliative Zweitlinientherapie mit CYRAMZA.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 303
- Publication type:
- Article
Hepatische Enzephalopathie - die folgenschwere Unbekannte.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 303
- Publication type:
- Article
Maßgeschneiderte Austauschsysteme für die gastrale Langzeiternährung.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 302
- Publication type:
- Article
Orale Autonomie ist möglich.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 302
- Publication type:
- Article
Helicobacter pylori - ein Angriff auf die Gesundheit.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 301
- Publication type:
- Article
DACED verleiht Zukunftspreis 2016.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 301
- Publication type:
- Article
Everolimus (Afinitor®) bietet neue Möglichkeiten für GI-NET.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 301
- Publication type:
- Article
ONIVYDE® erhält positive CHMP-Empfehlung zur Behandlung von Patienten mit metastasiertem Adenokarzinom des Pankreas nach Progress unter einer Gemcitabin-basierten Therapie.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 300
- Publication type:
- Article
Europäische Kommission erteilt Zulassung für Gileads Epclusa® (Sofosbuvir/Velpatasvir) zur Behandlung der chronischen Hepatitis C aller Genotypen.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 299
- Publication type:
- Article
Therapiemanagement bei gastrointestinalen Stromatumoren - warum sich patientenindividuelle Behandlung lohnen kann.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 299
- Publication type:
- Article
Biosimilar von Infliximab zugelassen.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 299
- Publication type:
- Article
LiMAx-Test revolutioniert die Leberfunktionsdiagnostik.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 298
- Publication type:
- Article
Beschleunigte FDA-Zulassung von Ocaliva® (Obeticholsäure) zur Behandlung der primär biliären Cholangitis.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 297
- Publication type:
- Article
Zugabe von Erbitux zu FOLFOX verbessert Ergebnisse signifikant bei mCRC vom RAS-Wildtyp.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 297
- Publication type:
- Article
Hohe HCV-Heilungsraten und sehr gute Verträglichkeit unter Daclatasvir (Daklinza®) auch bei Patienten mit absoluter Therapiebedürftigkeit.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 297
- Publication type:
- Article
Nierenfunktion wichtig für die Therapieentscheidung.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 296
- By:
- Publication type:
- Article
Patientenrekrutierung für drei neue Studien zur Behandlung von Pankreaskrebs gestartet.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 294
- Publication type:
- Article
Challenges in Liver Transplantation.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 290, doi. 10.1159/000448156
- By:
- Publication type:
- Article
Gender Mainstreaming and Transplant Surgery.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 286, doi. 10.1159/000446357
- By:
- Publication type:
- Article
Organ Transplantation in the Face of Donor Shortage - Ethical Implications with a Focus on Liver Allocation.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 278, doi. 10.1159/000446382
- By:
- Publication type:
- Article
Morbidity and Mortality Rounds in Liver Transplantation.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 272, doi. 10.1159/000446997
- By:
- Publication type:
- Article
HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 263, doi. 10.1159/000446385
- By:
- Publication type:
- Article
When and How to Treat HCV Infection with the New Antivirals before or after Liver Transplantation.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 258, doi. 10.1159/000446976
- By:
- Publication type:
- Article
Graft Reconditioning before Liver Transplantation.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 250, doi. 10.1159/000446378
- By:
- Publication type:
- Article
Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 241, doi. 10.1159/000446304
- By:
- Publication type:
- Article
NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 234, doi. 10.1159/000446379
- By:
- Publication type:
- Article
Challenges in Liver Transplantation.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 4, p. 232, doi. 10.1159/000448633
- By:
- Publication type:
- Article